Nagano, Nobuo http://orcid.org/0000-0001-6527-3286
Zushida, Chie
Tagahara, Ayaka
Miya, Masaaki
Tamei, Noriko
Muto, Shigeaki
Tsutsui, Takaaki
Ando, Tetsuo
Ogawa, Tetsuya
Ito, Kyoko
Article History
Received: 15 February 2023
Accepted: 21 July 2023
First Online: 14 August 2023
Declarations
:
: Consultancies: Nobuo Nagano (Kyowa Kirin Co., Ltd and Sanwa Kagaku Kenkyusho Co., Ltd), Honoraria: Nobuo Nagano (Kyowa Kirin Co., Ltd, Torii Pharmaceutical Co., Ltd, and Kissei Pharmaceutical Co., Ltd.). The other authors have declared that no conflict of interest exists.
: All procedures in studies involving human participants were performed in accordance with the ethical standards of the Hidaka Hospital Medical Ethics Committee (approval number: 348) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study did not include any animal studies performed by any of the authors.
: This was a retrospective analysis of drug prescription and routine blood chemistry records. Individual informed consent was not required, because many patients died or were transferred to other hospitals at the time of application to the institutional ethics committee.
: All authors gave consent for publication to the journal.